Site içinde arama yapın

EthanWalker bir ses eklendi Other
2026-10-23 22:16:07 - Translate -

Alvotech (ALVO) files first known Eylea 8 mg biosimilar application in Europe
Alvotech and Advanz Pharma sent AVT29 to the European Medicines Agency on 14 October 2026 as a line extension to Mynzepli, the Eylea 2 mg biosimilar. Alvotech (ALVO) and its partner Advanz Pharma submitted AVT29 to the European Medicines Agency on 14 October 2026, according to a company release issued the same day. AVT29 is a proposed biosimilar to Eylea 8 mg, the higher-dose form of...

0 Yorumlar 0 hisse senetleri 19 Views 0 önizleme

Please log in to like, share and comment!
Subhayan2 bir ses eklendi Other
2026-06-18 09:38:01 - Translate -

Global Diabetes Drugs Market Growing at 12.1% CAGR Through 2032
According to a new report from Intel Market Research, the global diabetes drugs market was valued at USD 99,880 million in 2024 and is projected to grow from USD 108,000 million in 2025 to USD 218,800 million by 2032, exhibiting a robust CAGR of 12.1% during the forecast period (2025–2032). This growth is driven by the rising global prevalence of diabetes, increased healthcare...

0 Yorumlar 0 hisse senetleri 2K Views 0 önizleme

Please log in to like, share and comment!